Safety of Contrast Agent Use During Stress Echocardiography. A 4-Year Experience From a Single-Center Cohort Study of 26,774 Patients

JACC: Cardiovascular Imaging

Volumn 2, Issue 9, 2009, Pages 1048-1056

  Abdelmoneim, Sahar S ^a,b   Bernier, Mathieu ^a   Scott, Christopher G ^a   Dhoble, Abhijeet ^a   Ness, Sue Ann C ^a   Hagen, Mary E ^a   Moir, Stuart ^a   McCully, Robert B ^a   Pellikka, Patricia A ^a   Mulvagh, Sharon L ^a  

^a MAYO CLINIC   (United States)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

contrast agent safety; echocardiography; ultrasonography

Indexed keywords

ADRENALIN; DIPHENHYDRAMINE; DOBUTAMINE; ECHO CONTRAST MEDIUM; FLUOROCARBON; PERFLUTREN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACKACHE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; NAUSEA AND VOMITING; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SHIVERING; STRESS ECHOCARDIOGRAPHY; SUPRAVENTRICULAR TACHYCARDIA; SWELLING; THORAX PAIN; THROAT DISEASE; TREMOR; URTICARIA; WHEEZING;

AGED; ALBUMINS; ARRHYTHMIAS, CARDIAC; CONTRAST MEDIA; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; FLUOROCARBONS; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 70149086779     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.03.020     Document Type: Article

References (21)

1. Rainbird A.J., Mulvagh S.L., Oh J.K., et al. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 14 (2001) 378-385
2. Cohen J.L., Cheirif J., Segar D.S., et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: results of a phase III Multicenter Trial. J Am Coll Cardiol 32 (1998) 746-752
3. Kitzman D.W., Goldman M.E., Gillam L.D., Cohen J.L., Aurigemma G.P., and Gottdiener J.S. Efficacy and safety of the novel ultrasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 86 (2000) 669-674
4. Online U.S. Food and Drug Administration Postmarket Drug Safety Information for patients and Providers. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm110260.htm Accessed November 6, 2008
5. Mulvagh S.L., Rakowski H., Vannan M.A., et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 21 (2008) 1179-1201
6. Pellikka P.A., Roger V.L., Oh J.K., Miller F.A., Seward J.B., and Tajik A.J. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 70 (1995) 16-27
7. Roger V.L., Pellikka P.A., Oh J.K., Miller F.A., Seward J.B., and Tajik A.J. Stress echocardiography. Part I. Exercise echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 70 (1995) 5-15
8. van Der Wouw P.A., Brauns A.C., Bailey S.E., Powers J.E., and Wilde A.A. Premature ventricular contractions during triggered imaging with ultrasound contrast. J Am Soc Echocardiogr 13 (2000) 288-294
9. Raisinghani A., Wei K.S., Crouse L., et al. Myocardial contrast echocardiography (MCE) with triggered ultrasound does not cause premature ventricular complexes: evidence from PB127 MCE studies. J Am Soc Echocardiogr 16 (2003) 1037-1042
10. Vancraeynest D., Kefer J., Hanet C., et al. Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J 28 (2007) 1236-1241
11. Borges A.C., Walde T., Reibis R.K., et al. Does contrast echocardiography with Optison induce myocardial necrosis in humans?. J Am Soc Echocardiogr 15 (2002) 1080-1086
12. Tsutsui J.M., Elhendy A., Xie F., O'Leary E.L., McGrain A.C., and Porter T.R. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 45 (2005) 1235-1242
13. Kane G.C., Hepinstall M.J., Kidd G.M., et al. Safety of stress echocardiography supervised by registered nurses: results of a 2-year audit of 15,404 patients. J Am Soc Echocardiogr 21 (2008) 337-341
14. Wei K., Mulvagh S.L., Carson L., et al. The safety of Definity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr 11 (2008) 1202-1206
15. Herzog C.A. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. JAMA 299 (2008) 2023-2025
16. Kusnetzky L.L., Khalid A., Khumri T.M., Moe T.G., Jones P.G., and Main M.L. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 patients. J Am Coll Cardiol 51 (2008) 1704-1706
17. Gabriel R.S., Smyth Y.M., Menon V., et al. Safety of ultrasound contrast agents in stress echocardiography. Am J Cardiol 102 (2008) 1269-1272
18. Main M.L., Ryan A.C., Davis T.E., Albano M.P., Kusnetzky L.L., and Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: multicenter results in 4,300,966 consecutive patients. Am J Cardiol 102 (2008) 1742-1746
19. Shaikh K., Chang S.M., Peterson L., et al. Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress. Am J Cardiol 102 (2008) 1444-1450
20. Dolan M.S., Gala S., Dodla S., et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography: a multicenter experience. J Am Coll Cardiol 53 (2009) 32-38
21. Aggeli C., Giannopoulos G., Roussakis G., et al. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for detection of ischemia in 5250 studies. Heart 94 (2008) 1571-1577